What Agimexpharm Pharmaceutical does

Agimexpharm Pharmaceutical JSC (Công ty Cổ Phần Dược phẩm Agimexpharm) is a Vietnamese pharmaceutical manufacturer founded in 1976 and headquartered in Long Xuyên, An Giang province. The company operates two GMP-certified manufacturing facilities in An Giang: a pharmaceutical and cosmetics plant in Mỹ Thới (inaugurated 2008) and a medicinal herbs and dietary supplements plant at the Bình Hòa Industrial Zone (inaugurated ~2018). It produces and distributes five product categories — pharmaceuticals (dược phẩm), medicinal materials (dược liệu), cosmetics (mỹ phẩm), health protection foods/dietary supplements (thực phẩm bảo vệ sức khỏe), and medical devices (thiết bị y tế) — meeting WHO-GMP and Vietnamese food safety standards. Agimexpharm is publicly listed on the Ho Chi Minh City Stock Exchange, with raw materials sourced from a global supplier network including BASF, Sanofi, Univar, Meggle, DFE Pharma, Glenmark, and others.

The company's business model rests on three revenue streams: (1) own-brand manufacturing and direct distribution through four wholly-owned regional branches (Ho Chi Minh City, Da Nang, Tay Nguyên/Buôn Ma Thuột, Hanoi) and a pharmacy booth at Hapulico in Hanoi, deployed via a field force of Medical Sales Representatives (Trình Dược Viên) into OTC pharmacy channels; (2) contract manufacturing and OEM services for third-party pharmaceutical and dietary supplement brand owners under GMP; and (3) product registration and market authorization services as part of its contract development offering. Agimexpharm serves two primary customer segments: pharmacy retailers and healthcare providers across Vietnam (SMB distribution via OTC channels) and brand owners/co-manufacturers seeking GMP-certified production capacity. Pricing is not publicly disclosed and contract manufacturing is quoted per project.

The company has ~235 workers (2017/2018 snapshot), 12 consecutive years of High Quality Vietnamese Goods certification as of 2025, and recognition from the Drug Administration (Ministry of Health) including the Ngôi Sao Thuốc Việt award in 2024. Its go-to-market is an enterprise field-sales model with regional branch coverage, supplemented by CSR-driven community engagement (health outreach missions, scholarships), content marketing via a medical knowledge portal, and active participation in Vietnamese pharmaceutical industry awards and trade fairs.

Name

Agimexpharm Pharmaceutical

Legal name

CÔNG TY CỔ PHẦN DƯỢC PHẨM AGIMEXPHARM

Website

https://agimexpharm.com

Company type

Public

Founded year

1976

Operating status

Operating

Headcount range

101–250 employees

Short description

Agimexpharm Pharmaceutical JSC is a Vietnamese GMP-certified pharmaceutical manufacturer, founded in 1976 and listed on the Ho Chi Minh City Stock Exchange, producing pharmaceuticals, medicinal herbs, cosmetics, dietary supplements, and medical devices across two An Giang factories and distributing nationwide through four regional branches into OTC pharmacy channels, plus offering contract manufacturing services to third-party brands.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing services
• Medicinal herb production
• Dietary supplements GMP
• Pharmaceutical distribution Vietnam

Headquarters

HQ city

Long Xuyên

HQ country

Vietnam

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Manufacturing & Sales: Manufacturing and direct sales of branded pharmaceutical products including drugs, medicinal herbs, cosmetics, dietary supplements, and medical devices through the company's own distribution network across Vietnam.
2. Contract Manufacturing (OEM/Third-party production): Provides manufacturing and contract processing services (hợp tác sản xuất, gia công) for third-party pharmaceutical and dietary supplement brands under GMP standards.
3. Product Registration Services: Offers product registration and market authorization (đăng ký lưu hành sản phẩm) services as part of its contract manufacturing and development offering.
4. Distribution & Trading: Business operations and distribution (kinh doanh và phân phối) of pharmaceutical and health products through the company's own branch network.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Agimexpharm Pharmaceutical manufactures and distributes a diversified portfolio of GMP-certified pharmaceutical, medicinal herb, cosmetic, dietary supplement, and medical device products from its two manufacturing facilities in An Giang province. The company also provides contract manufacturing (OEM), product development, and product registration services to third-party pharmaceutical and supplement brands, with its own nationwide distribution network reaching pharmacies and healthcare providers across Vietnam.

Product overview

Agimexpharm Pharmaceutical offers a diversified portfolio of five core product categories: Pharmaceuticals (dược phẩm), Medicinal Materials (dược liệu), Cosmetics (mỹ phẩm), Health Protection Foods (thực phẩm bảo vệ sức khỏe), and Medical Equipment (thiết bị Y tế). The company operates two manufacturing facilities in An Giang province – a pharmaceutical and cosmetics plant in Mỹ Thới and a medicinal materials and dietary supplements plant in Bình Hòa Industrial Zone. Beyond manufacturing, Agimexpharm provides contract manufacturing services, product development, and operates its own nationwide distribution network covering major cities including HCMC, Đà Nẵng, Tây Nguyên, and Hà Nội.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceuticals (Dược phẩm) Branded pharmaceutical products manufactured by Agimexpharm at the My Thoi factory (An Giang province) under WHO GMP standards, distributed through OTC pharmacy channels and the company's nationwide branch network. Designed for sale to pharmacies, drugstores, and healthcare providers across Vietnam.
• Medicinal Materials (Dược liệu) Medicinal herbs and natural materials processed at Agimexpharm's dedicated Binh Hoa Industrial Zone facility (An Giang province) for use in pharmaceutical and health supplement production. Sold to pharmacy retailers and used internally as inputs for the company's dietary supplement product line.
• Cosmetics (Mỹ phẩm) Cosmetic products manufactured by Agimexpharm at its pharmaceutical-grade My Thoi facility, meeting GMP standards. Distributed through pharmacy and retail channels to consumers across Vietnam.
• Dietary Supplements / Health Protection Foods (Thực phẩm bảo vệ sức khỏe) Dietary supplements and health protection foods produced under GMP standards at Agimexpharm's Binh Hoa Industrial Zone facility in An Giang. Includes a Certificate of Food Safety Facility Conditions. Distributed through pharmacy and OTC channels across Vietnam.
• Medical Equipment (Thiết bị Y tế) Medical devices and equipment distributed by Agimexpharm through its nationwide distribution network of regional branches and OTC pharmacy channels. Sold to healthcare providers, pharmacies, and end users in Vietnam.
• Contract Manufacturing (Hợp tác sản xuất / Gia công) OEM/contract manufacturing services for third-party pharmaceutical, cosmetic, and dietary supplement brand owners, produced under GMP standards at Agimexpharm's two An Giang facilities. Targeted at brand owners and co-manufacturers needing GMP-certified production capacity in Vietnam.
• Product Development (Phát triển sản phẩm) Pharmaceutical and health supplement product development service, supporting formulation and product innovation. Targeted at brand owners requiring R&D support ahead of contract manufacturing.
• Product Registration Service (Đăng ký lưu hành sản phẩm) Product registration and market authorization services supporting companies through Vietnamese Ministry of Health regulatory approvals. Bundled with contract manufacturing and product development offerings.

Quantifiable outcome

• One employee's air pressure differential improvement saved the company over 100 million VND while improving product quality and reducing energy consumption
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Bệnh viện Đa khoa Tỉnh An Giang (An Giang Provincial General Hospital)minorStrategic or Co-development Partner · 28 March 2026Agimexpharm partnered with An Giang Provincial General Hospital to conduct a health outreach mission at Tiên Hải island on March 28, 2026, providing free health examinations and medicine donations to island residents.
• BASFcoreTechnology or IntegrationBASF is a global leader in pharmaceutical excipients and active pharmaceutical ingredients (APIs). Agimexpharm sources high-quality raw materials from BASF for its pharmaceutical manufacturing operations, ensuring compliance with international quality standards.
• UNIVARcoreTechnology or IntegrationUNIVAR is a global chemical and ingredients distributor serving the pharmaceutical industry. Agimexpharm sources pharmaceutical-grade chemicals and ingredients from UNIVAR as part of its raw material supply chain.
• SANOFIcoreTechnology or IntegrationSANOFI is a major global pharmaceutical company. Agimexpharm sources pharmaceutical materials and ingredients from Sanofi as part of its supply chain for GMP-certified production.
• MEGGLEcoreTechnology or IntegrationMEGGLE is a leading global supplier of pharmaceutical excipients including lactose and other functional excipients used in solid dosage forms.
• DFE PharmacoreTechnology or IntegrationDFE Pharma is a specialist in pharmaceutical excipients and mineral sugar blends, supplying critical excipients for solid, semi-solid, and liquid pharmaceutical formulations.
• GlenmarkcoreTechnology or IntegrationGlenmark Pharmaceuticals is a global pharmaceutical company. Agimexpharm sources pharmaceutical materials and active ingredients from Glenmark for its manufacturing operations.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Pymepharco JSC: Vietnamese pharma manufacturer with WHO GMP-certified facilities producing branded and generic medicines. Directly comparable as a domestic GMP pharma peer serving OTC pharmacy channels.
• OPC Pharmaceutical JSC: Vietnamese pharmaceutical manufacturer specializing in herbal and traditional medicines. Comparable given Agimexpharm's medicinal herbs (dược liệu) manufacturing line at the Binh Hoa factory.
• DHG Pharmaceutical (Hau Giang Pharmaceutical JSC): One of Vietnam's largest listed pharmaceutical manufacturers producing branded and generic finished dosage forms. Directly comparable as a domestic Vietnamese pharma manufacturer with GMP facilities, multi-category portfolio, and nationwide pharmacy distribution.
• Traphaco JSC: Vietnamese pharmaceutical company combining traditional medicinal herbs with modern pharmaceuticals. Directly comparable given Agimexpharm's similar dual emphasis on dược liệu (herbal materials) and modern pharma manufacturing.
• Imexpharm Pharmaceutical JSC: Listed Vietnamese pharma manufacturer producing branded generics and contract manufacturing under GMP. Comparable in scale and product mix, also serving pharmacy distribution channels across Vietnam.
• Bidiphar (Binh Dinh Pharmaceutical & Medical Equipment JSC): Vietnamese listed pharma manufacturer producing Western and traditional medicines, dietary supplements, and medical devices. Comparable as a multi-category domestic GMP-certified pharma producer with nationwide distribution.

Broad incumbents

• Vietnam Pharmaceutical Corporation (Vinapharm): State-owned umbrella pharma group encompassing manufacturing, distribution, and import/export across Vietnam. Comparable as a broad incumbent operating in pharmaceutical manufacturing and wholesale distribution within the same domestic market.
• Daiichi Sankyo Vietnam: Vietnamese operations of Japanese multinational Daiichi Sankyo. Comparable as a foreign broad incumbent in branded prescription and consumer health products, competing for the same pharmacy and hospital channels in Vietnam.
• Sanofi Vietnam: Vietnamese subsidiary of global pharmaceutical major Sanofi. Comparable as a broad incumbent with overlapping prescription and consumer health product lines, and as one of Agimexpharm's key API suppliers.

Regional players

• Mega Lifesciences: Thai-headquartered pharma and nutraceutical company with extensive Southeast Asia distribution. Comparable as a regional player operating in branded pharma, dietary supplements, and herbal products across emerging Asian markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/agp2008

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agimexpharm Pharmaceutical